SF1670

Catalog No.S7310

For research use only.

SF1670 is a highly potent and specific PTEN inhibitor with IC50 of 2 μM.

SF1670 Chemical Structure

CAS No. 345630-40-2

Selleck's SF1670 has been cited by 17 publications

Purity & Quality Control

Choose Selective PTEN Inhibitors

Biological Activity

Description SF1670 is a highly potent and specific PTEN inhibitor with IC50 of 2 μM.
Targets
PTEN [1]
2 μM
In vitro

SF1670 shows potent cytotoxicity in HBEC, PC-3, H1299 cells with IC50 of 5 μM, 10 μM, 44 μM, respectively. In a mouse aortic ring matrigel angiogenesis model, SF1670 stimulates the angiogenic processes. [1] SF1670 augments chemoattractant-elicited PtdIns(3,4,5)P3 signaling in neutrophils and enhances neutrophil functions. [2]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
human T-cell M4ni[HBzd2yrZnXyZZRqd25iYYPzZZk> MXXJckB3cXS{bzDpcohq[mm2aX;uJI9nKGi3bXHuJHQu[2WubDDwdo9tcW[ncnH0bY9vNCCLQ{WwQVAvOSEQvF2= M{\ZS|EyOzV4MUGy
human T-cells M3\iR2N6fG:2b4jpZ4l1gSCjc4PhfS=> NE\TXY1EgXSxdH;4bYNqfHlibXXhd5Vz\WRiYXfhbY5{fCCqdX3hckBVNWOnbHzzMEBESzVyPUOuOUDPxE1? Mn34NVE{PTZzMUK=
In vivo Pretreatment of SF1670 (500 nM i.v.) augments bacteria-killing capability in neutropenic mice in both peritonitis and bacterial pneumonia, and decreases the mortality of neutropenia-related pneumonia. [2]

Protocol (from reference)

Kinase Assay:[1]
  • PTEN Inhibition Assay:

    To determine the dose response of potential PTEN inhibitors, doses of test compounds ranging from 1 nM to 250 uM (final reaction mix concentrations) are evaluated in the general PTEN inhibition assay. To obtain performed IC50 data, two separate rounds of the dose response assay are performed. In the first round, PTEN activity is tested in the presence of inhibitor at 10 fold serial dilutions ranging from 1 nM to 250 uM. Once the concentration range is determined, at which PTEN activity changes dramatically, two additional concentration data points within this range are added and the PTEN inhibition assay is then rerun for the second round. The PTEN inhibition IC50 is presented as the inhibitor concentration at which 50% of the PTEN activity. When the assay was run on multiple occasions and gave slightly different IC50 then those are reported as a range of IC50 found.

Cell Research:[1]
  • Cell lines: Human brain endothelial cells (HBEC), human prostate cancer cells (PC-3) and human non-small cell lung cancer cells (H1299)
  • Concentrations: ~1 mM
  • Incubation Time: 2 hours
  • Method: Cells are plated into 96-well plates in RPMI 1640 medium supplemented with 10% FBS and incubated overnight at 37°C. in an incubator containing an atmosphere of 5% CO2. The following day, the medium is replaced and cells are starved by placing in 100 uL of serum-free medium for 3 hours. Serially diluted test compounds are added to the wells and incubated with the cells for 2 hours at 37°C. Compounds are tested in a range from 1 mM to 0.1 nM depending on solubility. MTT is added to the wells at a final concentration of 5 μg/ml and incubated with the cells for 3 more hours. At the end of the incubation, the medium is aspirated and the MTT stain in the cells is dissolved by the addition of 100 μL DMSO. Optical density of each well is then measured at 570 nm using a SpectroMax Plus spectrophotometric plate reader. The IC50 determination from the data was made using Prism software.
Animal Research:[2]
  • Animal Models: Neutropenic mice
  • Dosages: 500 nM
  • Administration: Tail-vein injection

Solubility (25°C)

In vitro

DMSO 29 mg/mL warmed
(94.35 mM)
Ethanol 1 mg/mL warmed
(3.25 mM)
Water Insoluble

Chemical Information

Molecular Weight 307.34
Formula

C19H17NO3

CAS No. 345630-40-2
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CC(C)(C)C(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C(=O)C2=O

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy SF1670 | SF1670 supplier | purchase SF1670 | SF1670 cost | SF1670 manufacturer | order SF1670 | SF1670 distributor